Radiometer launches the next generation of transcutaneous monitoring in Canada

Radiometer has unveiled its Health Canada licensed TCM5 transcutaneous monitor, addressing the critical care needs of neonatal, pediatric, and adult patients, as well as sleep clinic.

With a sleek appearance, intuitive color touchscreen interface, and clear visual display, the all-new TCM5 design focuses on the end-user. The TCM5 transcutaneous monitor offers continuous, non-invasive monitoring of tcpO2 and tcpCO2 as well as Masimo SET® SpO2, perfusion index, and pulse rate in real-time. The unique sensors automatically recalibrate when placed in the calibration chamber, enabling highly reliable measurements even with prolonged use. High-definition on-board interactive tutorials minimize training requirements.

Initially available in Australia, Japan, New Zealand, South Africa, Switzerland, the United Arab Emirates, the United Kingdom, and the European Union among others, the TCM5 monitor offers a choice of two distinct versions tailored to customer and patient needs. The TCM5 BASIC monitor is ideal for diagnostic investigations in sleep clinics and respiratory care. Lightweight and compact with a clear numeric display, it enables accurate determination of ventilation and oxygenation status overnight. The dedicated sleep mode offers silent operation and a dark screen, ensuring that patients are not disturbed.

The premium TCM5 FLEX monitor is designed for critical care departments. It is particularly beneficial in neonatal intensive care due to its non-invasive nature. Numeric and trend displays, together with audible and visual alarms, instantly alert clinicians to any change in a patient’s status, enabling immediate intervention. For round-the-clock monitoring of neonates, a special NICU mode automatically monitors the duration of contact with the skin while the unique site time and temperature management controls balances sensor temperature and site time, helping to protect sensitive skin.

For more information about the TCM5 transcutaneous monitor, please contact Radiometer Canada.

About Radiometer

Whatever comes next, we make sure life comes first.

Radiometer develops, manufactures, and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing, and related IT management systems. Founded in 1935 and headquartered in Copenhagen, Denmark, Radiometer is a pioneer in blood gas testing, introducing the world’s first commercially available blood gas analyzer in 1954. Today, Radiometer products and solutions are used in hospitals, clinics, and laboratories in over 130 countries, providing information on critical parameters in acute care diagnostics. Through connected solutions, expert knowledge, and trusted partnership, we help health care professionals make diagnostic decisions to improve patient care.



Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Radiometer Medical. (2022, July 06). Radiometer launches the next generation of transcutaneous monitoring in Canada. News-Medical. Retrieved on May 28, 2024 from

  • MLA

    Radiometer Medical. "Radiometer launches the next generation of transcutaneous monitoring in Canada". News-Medical. 28 May 2024. <>.

  • Chicago

    Radiometer Medical. "Radiometer launches the next generation of transcutaneous monitoring in Canada". News-Medical. (accessed May 28, 2024).

  • Harvard

    Radiometer Medical. 2022. Radiometer launches the next generation of transcutaneous monitoring in Canada. News-Medical, viewed 28 May 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
A practical guide to critical parameters in acute care testing